Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details. This indicates restricted access to the record and replaces the usual content with an error screen.SummaryDifference19%

- Check39 days agoChange DetectedThe revision tag on the page updates from v3.6.5 to v3.6.6, indicating a new build. No study details, eligibility criteria, or results content were changed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page's revision stamp was updated from v3.6.4 to v3.6.5, indicating a frontend update to this ClinicalTrials.gov page.SummaryDifference0.0%

- Check68 days agoChange DetectedNo additions or deletions were found on the page. The current study details remain unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small system or UI update to the study record display.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating deployment of site updates; the study page content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.